Transgenic animal models support that Gch1 deficiency and reduced vascular BH4 accelerate atherosclerosis whereas supplementation of BH4 or Gch1 expression reverse these deficits and retard atherosclerosis (19, 35, 47). This evidence concerns the gene GCH1 and atherosclerosis.